Oxadiazole mannich bases: Synthesis and antimycobacterial activity
A series of oxadiazole mannich bases were synthesized by reacting oxadiazole derivatives, dapsone and appropriate aldehyde in the presence of methanol. The synthesized compounds were evaluated for antimycobacterial activity against Mycobacterium tuberculosis H 37Rv and INH resistant M. tuberculosis....
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2007-06, Vol.17 (12), p.3314-3316 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A series of oxadiazole mannich bases were synthesized by reacting oxadiazole derivatives, dapsone and appropriate aldehyde in the presence of methanol. The synthesized compounds were evaluated for antimycobacterial activity against
Mycobacterium tuberculosis H
37Rv and INH resistant
M. tuberculosis. Among the synthesized compounds, compound (
4) 3-{2-furyl[4-(4-{2-furyl[5-(2-naphthyloxymethyl)-2-thioxo-2,3-dihydro-1,3,4-oxadiazol-3-yl]methylamino}phenylsulfonyl)anilino]methyl}-5-(2-naphthyloxymethyl)-2,3-dihydro-1,3,4-oxadiazole-2-thione was found to be the most promising compound active against
M. tuberculosis H
37Rv and isoniazid (INH) resistant
M. tuberculosis with minimum inhibitory concentration (MIC) 0.1
μM & 1.10
μM respectively.
A series of oxadiazole mannich bases were synthesized by reacting oxadiazole derivatives, dapsone and appropriate aldehyde in the presence of methanol. The synthesized compounds were evaluated for antimycobacterial activity against
M. tuberculosis H
37Rv and INH resistant
M. tuberculosis. Among the synthesized compounds, compound (
4) 3-{2-furyl[4-(4-{2-furyl[5-(2-naphthyloxymethyl)-2-thioxo-2,3-dihydro-1,3,4-oxadiazol-3-yl]methylamino}phenylsulfonyl)anilino]methyl}-5-(2-naphthyloxymethyl)-2,3-dihydro-1,3,4-oxadiazole-2-thione was found to be the most promising compound active against
M. tuberculosis H
37Rv and isoniazid (INH) resistant
M. tuberculosis with Minimum inhibitory concentration (MIC) 0.1
μM & 1.10
μM respectively. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2007.04.004 |